Dealmaking Styles of Regional Players
As dealmakers, Japanese and mid-sized European drug companies both tend to favor regional, rather than worldwide, agreements. But Europeans tend to pay more upfront, a reflection of the fact that they often prefer to use equity rather than simply cash in making their payments.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.